臨床試驗

Transcranial Photobiomodulation for Bipolar Depression

NCT：NCT07510646 · NOT_YET_RECRUITING

NCT IDNCT07510646

狀態NOT_YET_RECRUITING

開始日期2026-07-01

完成時間2027-07-01

簡要摘要

This study the effectiveness and safety of light therapy device targeted at the brain using a wearable device, the Vielight RX Gamma as a treatment for bipolar depression. Up to forty patients with bipolar disorder will be enrolled into the study and will either receive active treatment with the Vielight RX Gamma or sham (inactive device). They will be administered the devices in clinic 5days/week for 6 weeks. Changes in disease symptoms, cognitive function, pain, quality of life and rest EEG changes will be assessed.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。